Niva Bupa Health Insurance Company · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
At 35.8%, EUM is 50 bps above the 26% regulatory cap. While management expects improvement via operating leverage, any slowdown in premium growth could delay compliance. Analyst raised this concern directly.
Group loss ratio increased 500 bps YoY due to mix shift toward larger corporates with lower loss ratios. The improvement expected in H2 is contingent on renewal pricing actions.
GST exemption means ITC is unavailable on certain overhead expenses. Management estimates some residual impact but expects pharmacy GST reduction and volume growth to more than compensate. Analyst specifically asked about quantum.
Voluntary quota share reinsurance treaty shifted from annual to quarterly settlement from May 2025, creating optical AUM stagnation. This could affect investment income timing and capital efficiency.
